ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is characterized by continuous activation of the BCR-ABL1 tyrosine kinase fusion gene, leading to activation of oncogenic signaling pathways.